+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Activin-A Market by Application, Product Type, Formulation, End User, Route Of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Activin-A Market by Application, Product Type, Formulation, End User, Route Of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Activin-A Market by Application, Product Type, Formulation, End User, Route Of Administration, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5305483
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Activin-A market is undergoing substantial transformation as biotechnology advances, evolving clinical needs, and a shifting regulatory backdrop steer new directions for growth and competition. Senior leaders requiring clear market foresight will benefit from an integrated perspective on opportunities, risk factors, and critical trends in this complex space.

Market Snapshot: Activin-A Market Growth Outlook

The Activin-A market grew from USD 287.73 million in 2024 to USD 316.71 million in 2025 and is expected to reach USD 499.04 million by 2030, reflecting a CAGR of 9.61%. This expansion is a result of new therapeutic and research applications, increasing commercial interest from established life science companies, and momentum from emerging biotechnologies.

Scope & Segmentation

This report provides a comprehensive analysis of the Activin-A market, with breakdowns across regions, product types, applications, and end users. It enables executives to navigate the sector’s complexity and adapt strategies for sustained performance.

  • Applications: Bone regeneration, drug discovery (high-throughput screening, target validation), tissue engineering (cardiac, neural, skin), wound healing (burn restoration, diabetic foot ulcer, pressure ulcer).
  • Product Types: Analogues with tailored bioactivity, biosimilar Activin-A, recombinant Activin-A for standardized research applications.
  • Formulation Options: Liquid solutions for immediate deployment, lyophilized powders designed for long-term storage, adaptable to different research timelines and clinical environments.
  • End Users: Academic research institutes, contract research organizations, hospitals and clinical centers, pharmaceutical biotech companies focusing on commercialization.
  • Routes of Administration: Injectable forms for systemic therapy, topical solutions for localized treatment and advanced wound healing applications.
  • Distribution Channels: Direct tender sales, distributors and retailers, online sales platforms suited for research entities and smaller buyers.
  • Regions: Americas (including U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (major Western and emerging regional countries), Asia-Pacific (China, India, Japan, Australia, and additional key markets).
  • Key Companies: Thermo Fisher Scientific Inc., Merck KGaA, Bio-Techne Corporation, Abcam plc, Qiagen N.V., GenScript Biotech Corporation, Sino Biological Inc., RayBiotech Life Inc., Proteintech Group, Enzo Life Sciences.

Key Takeaways for Decision Makers

  • Scientific breakthroughs and advances in formulation technologies, such as advanced lyophilization, are expanding therapeutic and diagnostic use cases for Activin-A.
  • Collaboration between academic research institutes, biopharma, and contract research organizations is reshaping go-to-market strategies, improving innovation timelines, and expanding assay service offerings.
  • Integration of digital health platforms is optimizing clinical trial processes, providing competitive advantages and accelerating translational applications.
  • Growth in biosimilar and analogue Activin-A solutions is addressing price-sensitive markets and diversifying product portfolios for more resilient supply strategies.
  • Regional adoption patterns require tailored entry strategies, with Asia-Pacific showing strong investment in manufacturing, and the Americas benefiting from supporting infrastructure and funding for advanced research.

Tariff Impact: 2025 US Import Duties

The introduction of new U.S. tariffs on biologic imports in 2025 has increased costs along the Activin-A supply chain. Manufacturers and developers relying on imported recombinant proteins have had to review sourcing models and renegotiate supplier agreements. Companies are now prioritizing local production partnerships to mitigate future tariff risk, though these strategies demand significant investment and transition time. Additionally, organizations are exploring alternate formulations and accelerating biosimilar development to minimize cost exposure and maintain market competitiveness.

Methodology & Data Sources

This market intelligence is underpinned by a rigorous blend of primary interviews, peer-reviewed literature, regulatory disclosures, patent analysis, and financial filings. Segmentation and regional assessments were validated with stakeholders from both the research and commercial sectors to ensure relevance for executive decision-making.

Why This Report Matters

  • Enables senior executives to identify and act on high-value opportunities in Activin-A-based applications, responding quickly to shifting market and regulatory landscapes.
  • Delivers actionable segmentation and regional strategy insights for optimizing product pipelines, partnerships, and market access initiatives.
  • Provides a concise, sector-wide analysis essential for investment planning and risk mitigation in biotechnology and therapeutic innovation.

Conclusion

By integrating scientific, commercial, and policy insights, this report equips decision-makers to anticipate trends, allocate resources efficiently, and sustain competitive strength as the Activin-A market evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Activin-A Market, by Application
8.1. Introduction
8.2. Bone Regeneration
8.3. Drug Discovery
8.3.1. High Throughput Screening
8.3.2. Target Validation
8.4. Tissue Engineering
8.4.1. Cardiac Tissue Engineering
8.4.2. Neural Tissue Engineering
8.4.3. Skin Tissue Engineering
8.5. Wound Healing
8.5.1. Burn Restoration
8.5.2. Diabetic Foot Ulcer
8.5.3. Pressure Ulcer
9. Activin-A Market, by Product Type
9.1. Introduction
9.2. Analogues
9.3. Biosimilar Activin-A
9.4. Recombinant Activin-A
10. Activin-A Market, by Formulation
10.1. Introduction
10.2. Liquid Solution
10.3. Lyophilized Powder
11. Activin-A Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals And Clinics
11.5. Pharmaceutical Biotech Companies
12. Activin-A Market, by Route Of Administration
12.1. Introduction
12.2. Injectable
12.3. Topical
13. Activin-A Market, by Distribution Channel
13.1. Introduction
13.2. Direct Tender Sales
13.3. Distributors And Retailers
13.4. Online Sales
14. Americas Activin-A Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Activin-A Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Activin-A Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Bio-Techne Corporation
17.3.4. Abcam plc
17.3.5. Qiagen N.V.
17.3.6. GenScript Biotech Corporation
17.3.7. Sino Biological Inc.
17.3.8. RayBiotech Life Inc.
17.3.9. Proteintech Group, Inc.
17.3.10. Enzo Life Sciences, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ACTIVIN-A MARKET MULTI-CURRENCY
FIGURE 2. ACTIVIN-A MARKET MULTI-LANGUAGE
FIGURE 3. ACTIVIN-A MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ACTIVIN-A MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ACTIVIN-A MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ACTIVIN-A MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ACTIVIN-A MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ACTIVIN-A MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ACTIVIN-A MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ACTIVIN-A MARKET SIZE, BY CARDIAC TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ACTIVIN-A MARKET SIZE, BY NEURAL TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ACTIVIN-A MARKET SIZE, BY SKIN TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ACTIVIN-A MARKET SIZE, BY BURN RESTORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ACTIVIN-A MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ACTIVIN-A MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ACTIVIN-A MARKET SIZE, BY ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ACTIVIN-A MARKET SIZE, BY BIOSIMILAR ACTIVIN-A, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ACTIVIN-A MARKET SIZE, BY RECOMBINANT ACTIVIN-A, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ACTIVIN-A MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ACTIVIN-A MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ACTIVIN-A MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ACTIVIN-A MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ACTIVIN-A MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ACTIVIN-A MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ACTIVIN-A MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ACTIVIN-A MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ACTIVIN-A MARKET SIZE, BY DIRECT TENDER SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ACTIVIN-A MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ACTIVIN-A MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. CANADA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 63. CANADA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 64. CANADA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 65. CANADA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. GERMANY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. GERMANY ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 118. GERMANY ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 119. GERMANY ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 120. GERMANY ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. FRANCE ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 127. FRANCE ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 128. FRANCE ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 129. FRANCE ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 131. FRANCE ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. FRANCE ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. FRANCE ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. ITALY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. ITALY ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 145. ITALY ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 146. ITALY ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 147. ITALY ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. ITALY ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 149. ITALY ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. ITALY ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. ITALY ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. SPAIN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. SPAIN ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 154. SPAIN ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 155. SPAIN ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 156. SPAIN ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SPAIN ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 158. SPAIN ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SPAIN ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. SPAIN ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. DENMARK ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. DENMARK ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 190. DENMARK ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 191. DENMARK ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 192. DENMARK ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. DENMARK ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 194. DENMARK ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. DENMARK ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. DENMARK ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. QATAR ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. QATAR ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 208. QATAR ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 209. QATAR ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 210. QATAR ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. QATAR ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. QATAR ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. QATAR ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. QATAR ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. FINLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. FINLAND ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 217. FINLAND ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 218. FINLAND ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 219. FINLAND ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. FINLAND ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. EGYPT ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. EGYPT ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 244. EGYPT ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 245. EGYPT ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 246. EGYPT ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. EGYPT ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. EGYPT ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. EGYPT ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. TURKEY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. TURKEY ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 253. TURKEY ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 254. TURKEY ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 255. TURKEY ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. TURKEY ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 257. TURKEY ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. TURKEY ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. TURKEY ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. NORWAY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. NORWAY ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 271. NORWAY ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 272. NORWAY ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 273. NORWAY ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. NORWAY ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 275. NORWAY ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. NORWAY ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. POLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. POLAND ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 280. POLAND ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 281. POLAND ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 282. POLAND ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. POLAND ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 284. POLAND ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. POLAND ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 286. POLAND ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 306. CHINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. CHINA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 308. CHINA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 309. CHINA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 310. CHINA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. CHINA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 312. CHINA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. CHINA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. CHINA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. INDIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. INDIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 317. INDIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 318. INDIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 319. INDIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. INDIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 321. INDIA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. INDIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 323. INDIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. JAPAN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. JAPAN ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 326. JAPAN ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 327. JAPAN ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 328. JAPAN ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. JAPAN ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 330. JAPAN ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. JAPAN ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 332. JAPAN ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. AUSTRALIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 345. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 351. INDONESIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 360. THAILAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 361. THAILAND ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 362. THAILAND ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 363. THAILAND ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 364. THAILAND ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 365. THAILAND ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 366. THAILAND ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 367. THAILAND ACTIVIN-A MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 368. THAILAND ACTIVIN-A MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 369. PHILIPPINES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 370. PHILIPPINES ACTIVIN-A MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 371. PHILIPPINES ACTIVIN-A MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 372. PHILIPPINES ACTIVIN-A MARKET SIZE, BY WOUND HEALING, 2018-2030 (USD MILLION)
TABLE 373. PHILIPPINES ACTIVIN-A MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 374. PHILIPPINES ACTIVIN-A MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 375. PHILIPPINES ACTIVIN-A MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 376. PHILIPPINES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Activin-A market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Techne Corporation
  • Abcam plc
  • Qiagen N.V.
  • GenScript Biotech Corporation
  • Sino Biological Inc.
  • RayBiotech Life Inc.
  • Proteintech Group, Inc.
  • Enzo Life Sciences, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 316.71 Million
Forecasted Market Value ( USD ) by 2030 $ 499.04 Million
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antimicrobial Peptides Market by Source, Structure, Mechanism of Action, Application - Global Forecast to 2030 - Product Image

Antimicrobial Peptides Market by Source, Structure, Mechanism of Action, Application - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Centella Asiatica Market by Plant Part, Product Variety, Product Form, Distribution Channel, End User, Application - Global Forecast to 2030 - Product Image

Centella Asiatica Market by Plant Part, Product Variety, Product Form, Distribution Channel, End User, Application - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Nucleic Acid Methylation Market Size, Share & Trends Analysis Report by Product & Services (Kits & Reagents, Enzymes), Type (DNA Methylation, RNA Methylation), Technology, Application, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Nucleic Acid Methylation Market Size, Share & Trends Analysis Report by Product & Services (Kits & Reagents, Enzymes), Type (DNA Methylation, RNA Methylation), Technology, Application, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Piperazine Market Size, Share & Trend Analysis Report, Source (Natural, Synthetic), End-Use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics), and Region (North America, Europe, APAC) with Growth Forecasts, 2025-2030 - Product Image

Piperazine Market Size, Share & Trend Analysis Report, Source (Natural, Synthetic), End-Use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics), and Region (North America, Europe, APAC) with Growth Forecasts, 2025-2030

  • Report
  • 80 Pages
  • Global
From
Antimicrobial Peptides - Global Strategic Business Report - Product Image

Antimicrobial Peptides - Global Strategic Business Report

  • Report
  • 471 Pages
  • Global
From

About the Activin A Market

Activin A is a member of the transforming growth factor-beta (TGF-β) superfamily of proteins, and is a homodimeric glycoprotein hormone. It is involved in a wide range of biological processes, including cell growth, differentiation, apoptosis, and immune regulation. Activin A is produced by a variety of cell types, including fibroblasts, macrophages, and endothelial cells. It is also found in a variety of tissues, including the brain, heart, and reproductive organs. Activin A is used in a variety of research applications, including cell culture, drug discovery, and disease modeling. It is also used in the development of therapeutic agents for a range of diseases, including cancer, diabetes, and cardiovascular disease. The Activin A market is composed of a variety of companies that produce and supply Activin A for research and therapeutic applications. These companies include Abcam, Merck KGaA, R&D Systems, Sigma-Aldrich, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.